Organometallic compounds as new drugs? Cobalt-containing aspirin complex with potential anti-tumor properties

Despite considerable progress in modern chemotherapy, there remains a large demand for innovative anti-tumor agents. A new approach involves modeling the pharmacological properties of established drugs with organometallic fragments. As a team of scientists from Berlin and Bochum (Germany), Innsbruck (Austria), and Leiden (The Netherlands) report in the journal Angewandte Chemie, cobalt-aspirin complexes have potential as cytostatics.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news151046764.html">Organometallic compounds as new drugs? Cobalt-containing aspirin complex with potential anti-tumor properties</a></p> <p>Despite considerable progress in modern chemotherapy, there remains a large demand for innovative anti-tumor agents. A new approach involves modeling the pharmacological properties of established drugs with organometallic fragments. As a team of scientists from Berlin and Bochum (Germany), Innsbruck (Austria), and Leiden (The Netherlands) report in the journal <i>Angewandte Chemie</i>, cobalt-aspirin complexes have potential as cytostatics.</p>